Profil
Brent Meadows served as the Chief Business Officer at Medicenna Therapeutics Corp.
in 2023 and previously held the same position at OncoOne Research & Development GmbH.
He earned an MBA from Babson College and an undergraduate degree from the University of Richmond.
Anciens postes connus de Brent Meadows
| Sociétés | Poste | Fin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Corporate Officer/Principal | 26/10/2023 |
OncoOne Research & Development GmbH
 OncoOne Research & Development GmbH BiotechnologyHealth Technology OncoOne Research & Development GmbH engages in the research in as well as the development, manufacturing, and commercialization of therapeutics, specifically in the field of oncology. It specializes in the development of drugs and novel therapeutics for the treatment of solid tumor cancers. The company was founded by Randolf Kerschbaumer, Michael Thiele, and Alexander Schinagl in June 2018 and is headquartered in Klosterneuburg, Austria. | Corporate Officer/Principal | - |
Formation de Brent Meadows
| Babson College | Masters Business Admin |
| University of Richmond | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDICENNA THERAPEUTICS CORP. | Health Technology |
| Entreprise privées | 1 |
|---|---|
OncoOne Research & Development GmbH
OncoOne Research & Development GmbH BiotechnologyHealth Technology OncoOne Research & Development GmbH engages in the research in as well as the development, manufacturing, and commercialization of therapeutics, specifically in the field of oncology. It specializes in the development of drugs and novel therapeutics for the treatment of solid tumor cancers. The company was founded by Randolf Kerschbaumer, Michael Thiele, and Alexander Schinagl in June 2018 and is headquartered in Klosterneuburg, Austria. | Health Technology |